Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1893-1900

  Brodin, O ^a   Nou, E ^a   Mercke, C ^b   Linden C J ^c   Lundstrom R ^d   Arwidi, Å ^c   Brink, J ^a   Ringborg, U ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemotherapy; Local control; Radiotherapy; Squamous cell carcinoma of the lung; Survival

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LEUKOPENIA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0030271670     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00212-2     Document Type: Article

References (32)

1. 1. Bulzenbruck H, Drings P, Kayser K, Schulz V, Tuengerthal S, Vogt-Moykopf I. Classification of lung cancer: first experience with the new TNM classification. Eur Respir J 1991, 4, 1197-1206.
2. 2. Mountain CF. A new international staging system for lung cancer. Chest 1986, 89, 225s-233s.
3. 3. Green M, Brodin O, Choi N, et al. Pre-operative and post-operative treatments in stage III NSCLC. Lung Cancer 1994, 10(Suppl. 1), S15-S17.
4. 4. Goldstraw P. Selection for surgery in advanced stage NSCLC. IASLC Workshop, Controversies in staging and treatment of locally advanced non small cell lung cancers, Bruges, 1993.
5. 5. Cox JD, Sause WT, Byhardt RW, Komaki R, Perez CA, Pajak TF. Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies. Lung Cancer 1994, 10(Suppl. 1), S161-S166.
6. 6. De Vita VT, Hellman S, Rosenberg S. Cancer. Principles and Practice of Oncology. Philadelphia, Lippincott, 1982, 435.
7. 7. Sause WT, Pajak T, Emami B, Byhardt R, Herskovic A, Cox JD. The Radiation Therapy Oncology Group experience altered fractionation in lung cancer. Lung Cancer 1993, 9, 229-238.
8. 8. Brodin O, Lennartsson L, Nilsson S. Single and fractionated dose irradiation of four human lung cancer cell lines in vitro. Acta Oncol 1990, 30, 867-874.
9. 9. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Cancer 1980, 45, 2744-2753.
10. 10. Bergh J, Larsson R, Nygren P. Resistance to chemotherapeutic drugs in human lung cancer: is circumvention possible? Lung Cancer 1993, 9, 307-316.
11. 11. Gralla RJ, Casper ES, Kelsen DP, et al. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules. Ann Intern Med 1981, 95, 414-420.
12. 12. Klastersky J, Nicaise C, Longeval E, et al. and the EORTC Lung Cancer Working Party (Belgium). Cisplatin and etoposide with or without vindesine in non small cell lung cancer. The III World Conference on Lung Cancer, Tokyo, 1982, Abstract 274.
13. 13. Zubrod CG, Schneiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960, 11, 7-23.
14. 14. Feld R, Borges M, Giner V, et al. Prognostic factors in non-small cell lung cancer. Lung Cancer 1994, 11(Suppl. 3), S19-S23.
15. 15. Mattson K, Holsti LR, Holsti P, et al. Inoperable non-small cell lung cancer radiation with or without chemotherapy. Int J Cancer Clin Oncol 1988, 24, 477-482.
16. 16. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990, 323, 940-945.
17. 17. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991, 83, 417-423.
18. 18. Le Chavelier T, Arriagada R, Tarayre M, et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 1992, 84, 58.
19. 19. Morton RF, Jett JR, McGinnis WL, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 1991, 115, 681-686.
20. 20. Crino L, Meacci M, Corgna E, et al. Long-term results in locally advanced inoperable non-small-cell lung cancer: a randomized trial of induction chemotherapy plus radiotherapy vs radiotherapy alone. Lung Cancer 1991, 7(Suppl.), 161.
21. 21. Wolf M, Havemann K, Hans K. Radiotherapy versus chemotherapy followed by radiotherapy in inoperable limited stage non-small-cell lung cancer. Lung Cancer 1991, 7(Suppl.), 164.
22. 22. Gregor A, Macbeth FR, Paul J, Cram L, Hansen HH. Raadical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial. J Natl Cancer Inst 1993, 85, 997-999.
23. 23. Green MR. Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: the right chemotherapy works in the right setting. In De Vita VT, Hellman S, Rosenberg S, eds. Important Advances in Oncology. Philadelphia, Lippincott, 1993, 125137.
24. 24. Ihde DC. Chemotherapy combined with chest irradiation for locally advanced non-small cell lung cancer. Ann Intern Med 1991, 115, 737-739.
25. 25. Tannock IF, Boyer M. When is cancer treatment worthwhile? N Engl J Med 1990, 323, 989-990.
26. 26. Green MR, Unresectable stage III non-small-cell lung cancer: lessons and directions from clinical trials research. J Natl Cancer Inst 1991, 83, 382-383.
27. 27. Stewart LA, Pignon JP, Parmar MKB, Arriagada R, Souhami RL. On behalf of the NSCLC Collaborative Group. A metaanalysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) using updated individual patient data. Lung Cancer 1994, 11(Suppl. 2), 49-50.
28. 28. Saunders MI, Bennett MH, Path FRC, et al. Primary tumour control after radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1984, 10, 499-501.
29. 29. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988, 27, 131-146.
30. 30. Schaake-Konig C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992, 326, 524-530.
31. 31. Saunders MI, Dische S, Grosch EJ, et al. Experience with CHART. Int J Radiat Oncol Biol Phys 1991, 21, 871-878.
32. 32. Kobayashi K, Ratain MJ. New perspectives on the toxicity of etoposide. Semin Oncol 1992, 19(Suppl. 13), 78-83.